IMMUNOGLOBULIN G1, ANTI-(HUMAN 5'-NUCLEOTIDASE) (HUMAN MONOCLONAL MEDI9447 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI9447 .LAMBDA.-CHAIN, DIMER
Luminal B
Jules Bordet Institutemonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Luminal B cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ribociclib Danish Breast Cancer Cooperative Group | Phase 3 | BB |
Durvalumab Jules Bordet Institute | Phase 2 | B |
Trastuzumab Deruxtecan Danish Breast Cancer Cooperative Group | Phase 3 | B |
Abemaciclib Danish Breast Cancer Cooperative Group | Phase 3 | B |
Letrozole University Hospital, Akershus | Phase 2 | B |
Zoladex University Hospital, Akershus | Phase 2 | B |
Epirubicin Grand Hôpital de Charleroi | Phase 1/2 | CCC |
Cyclophosphamide Grand Hôpital de Charleroi | Phase 1/2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN 5'-NUCLEOTIDASE) (HUMAN MONOCLONAL MEDI9447 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI9447 .LAMBDA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →